Chisayo Kozuka1, Sumito Sunagawa1, Rei Ueda1, Moritake Higa1,2, Yuzuru Ohshiro1,3, Hideaki Tanaka1,4, Chigusa Shimizu-Okabe5, Chitoshi Takayama5, Masayuki Matsushita6, Masato Tsutsui7, Shogo Ishiuchi8, Masanori Nakata9, Toshihiko Yada9, Jun-Ichi Miyazaki10, Seiichi Oyadomari11, Michio Shimabukuro12, Hiroaki Masuzaki1. 1. Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), University of the Ryukyus, Okinawa, Japan. 2. The Diabetes and Life-Style Related Disease Center, Tomishiro Central Hospital, Okinawa, Japan. 3. Okinawa Daiichi Hospital, Okinawa, Japan. 4. Tanaka Clinic, Okinawa, Japan. 5. Department of Molecular Anatomy, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. 6. Department of Molecular and Cellular Physiology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. 7. Department of Pharmacology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. 8. Department of Neurosurgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. 9. Division of Integrative Physiology, Department of Physiology, Jichi Medical University School of Medicine, Tochigi, Japan. 10. Division of Stem Cell Regulation Research, Osaka University Graduate School of Medicine, Osaka, Japan. 11. Institute for Genome Research, University of Tokushima, Tokushima, Japan. 12. Department of Cardio-Diabetes Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Abstract
BACKGROUND AND PURPOSE: γ-Oryzanol, derived from unrefined rice, attenuated the preference for dietary fat in mice, by decreasing hypothalamic endoplasmic reticulum stress. However, no peripheral mechanisms, whereby γ-oryzanol could ameliorate glucose dyshomeostasis were explored. Dopamine D2 receptor signalling locally attenuates insulin secretion in pancreatic islets, presumably via decreased levels of intracellular cAMP. We therefore hypothesized that γ-oryzanol would improve high-fat diet (HFD)-induced dysfunction of islets through the suppression of local D2 receptor signalling. EXPERIMENTAL APPROACH: Glucose metabolism and regulation of molecules involved in D2 receptor signalling in pancreatic islets were investigated in male C57BL/6J mice, fed HFD and treated with γ-oryzanol . In isolated murine islets and the beta cell line, MIN6 , the effects of γ-oryzanol on glucose-stimulated insulin secretion (GSIS) was analysed using siRNA for D2 receptors and a variety of compounds which alter D2 receptor signalling. KEY RESULTS: In islets, γ-oryzanol enhanced GSIS via the activation of the cAMP/PKA pathway. Expression of molecules involved in D2 receptor signalling was increased in islets from HFD-fed mice, which were reciprocally decreased by γ-oryzanol. Experiments with siRNA for D2 receptors and D2 receptor ligands in vitro suggest that γ-oryzanol suppressed D2 receptor signalling and augmented GSIS. CONCLUSIONS AND IMPLICATIONS: γ-Oryzanol exhibited unique anti-diabetic properties. The unexpected effects of γ-oryzanol on D2 receptor signalling in islets may provide a novel; natural food-based, approach to anti-diabetic therapy.
BACKGROUND AND PURPOSE: γ-Oryzanol, derived from unrefined rice, attenuated the preference for dietary fat in mice, by decreasing hypothalamic endoplasmic reticulum stress. However, no peripheral mechanisms, whereby γ-oryzanol could ameliorate glucose dyshomeostasis were explored. Dopamine D2 receptor signalling locally attenuates insulin secretion in pancreatic islets, presumably via decreased levels of intracellular cAMP. We therefore hypothesized that γ-oryzanol would improve high-fat diet (HFD)-induced dysfunction of islets through the suppression of local D2 receptor signalling. EXPERIMENTAL APPROACH: Glucose metabolism and regulation of molecules involved in D2 receptor signalling in pancreatic islets were investigated in male C57BL/6J mice, fed HFD and treated with γ-oryzanol . In isolated murine islets and the beta cell line, MIN6 , the effects of γ-oryzanol on glucose-stimulated insulin secretion (GSIS) was analysed using siRNA for D2 receptors and a variety of compounds which alter D2 receptor signalling. KEY RESULTS: In islets, γ-oryzanol enhanced GSIS via the activation of the cAMP/PKA pathway. Expression of molecules involved in D2 receptor signalling was increased in islets from HFD-fed mice, which were reciprocally decreased by γ-oryzanol. Experiments with siRNA for D2 receptors and D2 receptor ligands in vitro suggest that γ-oryzanol suppressed D2 receptor signalling and augmented GSIS. CONCLUSIONS AND IMPLICATIONS: γ-Oryzanol exhibited unique anti-diabetic properties. The unexpected effects of γ-oryzanol on D2 receptor signalling in islets may provide a novel; natural food-based, approach to anti-diabetic therapy.
Authors: Isabel García-Tornadú; Ana M Ornstein; Astrid Chamson-Reig; Michael B Wheeler; David J Hill; Edith Arany; Marcelo Rubinstein; Damasia Becu-Villalobos Journal: Endocrinology Date: 2010-02-10 Impact factor: 4.736
Authors: Norman Simpson; Antonella Maffei; Matthew Freeby; Steven Burroughs; Zachary Freyberg; Jonathan Javitch; Rudolph L Leibel; Paul E Harris Journal: Mol Endocrinol Date: 2012-08-21
Authors: Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar Journal: Br J Pharmacol Date: 2013-12 Impact factor: 8.739
Authors: Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar Journal: Nucleic Acids Res Date: 2013-11-14 Impact factor: 16.971
Authors: M D Milan Gowda; K Jayachandra; Vikram Joshi; Vaddarahally N Manjuprasanna; Gotravalli V Rudresha; Devadasan Velmurugan; Raman Pachaiappan; Noor Mohamed Jameel; Bannikuppe S Vishwanath Journal: Inflammopharmacology Date: 2022-05-31 Impact factor: 5.093